Colesevelam for Children With Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 236 participants.

Also called NCT01258075

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 236 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01258075
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01258075. Randomized; double masking; primary purpose treatment. Start 2011-02-24 (actual); primary completion 2019-11-01 (actual). Results posted on 2020-12-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colesevelam for Children With Type 2 Diabetes
Acronym
WELKid DM
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
High-dose colesevelam
Intervention (Drug)
Low-dose colesevelam
Lead sponsor
Daiichi Sankyo (class: industry)

Record details

Record id
cardio:ct-nct01258075
Content hash
0bdc3123997c4f58d25f8c9096dab7785e3a5268e25d221056c04d28c3176d1f